Literature DB >> 33176578

Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF.

Yan Deng1,2, Maodi Xie1,2, Qian Li1,2, Xuewen Xu3, Wei Ou1, Yabing Zhang1,2, Haitao Xiao3, Hai Yu1,2, Yanyi Zheng1,2, Yu Liang1,2, Chunling Jiang1,2, Guo Chen1,2, Dan Du1, Wen Zheng1, Shisheng Wang1, Meng Gong1, Yaohui Chen4, Rong Tian5, Tao Li1,2.   

Abstract

RATIONALE: Over 50% of patients with heart failure have preserved ejection fraction (HFpEF), rather than reduced ejection fraction. Complexity of its pathophysiology and the lack of animal models hamper the development of effective therapy for HFpEF.
OBJECTIVE: This study was designed to investigate the metabolic mechanisms of HFpEF and test therapeutic interventions using a novel animal model. METHODS AND
RESULTS: By combining the age, long-term high-fat diet, and desoxycorticosterone pivalate challenge in a mouse model, we were able to recapture the myriad features of HFpEF. In these mice, mitochondrial hyperacetylation exacerbated while increasing ketone body availability rescued the phenotypes. The HFpEF mice exhibited overproduction of IL (interleukin)-1β/IL-18 and tissue fibrosis due to increased assembly of NLPR3 inflammasome on hyperacetylated mitochondria. Increasing β-hydroxybutyrate level attenuated NLPR3 inflammasome formation and antagonized proinflammatory cytokine-triggered mitochondrial dysfunction and fibrosis. Moreover, β-hydroxybutyrate downregulated the acetyl-CoA pool and mitochondrial acetylation, partially via activation of CS (citrate synthase) and inhibition of fatty acid uptake.
CONCLUSIONS: Therefore, we identify the interplay of mitochondrial hyperacetylation and inflammation as a key driver in HFpEF pathogenesis, which can be ameliorated by promoting β-hydroxybutyrate abundance.

Entities:  

Keywords:  fibrosis; heart failure; inflammasomes; inflammation; mitochondria

Mesh:

Substances:

Year:  2020        PMID: 33176578     DOI: 10.1161/CIRCRESAHA.120.317933

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  55 in total

Review 1.  Metabolic, structural and biochemical changes in diabetes and the development of heart failure.

Authors:  Kim L Ho; Qutuba G Karwi; David Connolly; Simran Pherwani; Ezra B Ketema; John R Ussher; Gary D Lopaschuk
Journal:  Diabetologia       Date:  2022-01-07       Impact factor: 10.122

Review 2.  Animal Models of Dysregulated Cardiac Metabolism.

Authors:  Heiko Bugger; Nikole J Byrne; E Dale Abel
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

Review 3.  Signaling pathways in obesity: mechanisms and therapeutic interventions.

Authors:  Xue Wen; Bohan Zhang; Beiyi Wu; Haitao Xiao; Zehua Li; Ruoyu Li; Xuewen Xu; Tao Li
Journal:  Signal Transduct Target Ther       Date:  2022-08-28

Review 4.  Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?

Authors:  Salva R Yurista; Shi Chen; Aidan Welsh; W H Wilson Tang; Christopher T Nguyen
Journal:  Curr Heart Fail Rep       Date:  2022-05-14

Review 5.  Cardiac Energy Metabolism in Heart Failure.

Authors:  Gary D Lopaschuk; Qutuba G Karwi; Rong Tian; Adam R Wende; E Dale Abel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

6.  Hypoxic acclimation improves cardiac redox homeostasis and protects heart against ischemia-reperfusion injury through upregulation of O-GlcNAcylation.

Authors:  Wei Ou; Yu Liang; Yu Qin; Wei Wu; Maodi Xie; Yabing Zhang; Yarong Zhang; Liwei Ji; Haiyang Yu; Tao Li
Journal:  Redox Biol       Date:  2021-04-30       Impact factor: 11.799

7.  β-Hydroxybutyrate, One of the Three Main Ketone Bodies, Ameliorates Acute Pancreatitis in Rats by Suppressing the NLRP3 Inflammasome Pathway.

Authors:  Erhan Şahin; N Ezgi Bektur Aykanat; Sedat Kacar; Rıdvan Bagci; Varol Sahinturk
Journal:  Turk J Gastroenterol       Date:  2021-08       Impact factor: 1.852

8.  Metabolism and Inflammation in Cardiovascular Health and Diseases: Mechanisms to Therapies.

Authors:  Gabriele G Schiattarella; Yibin Wang; Rong Tian; Joseph A Hill
Journal:  J Mol Cell Cardiol       Date:  2021-03-02       Impact factor: 5.763

9.  A Porcine Model of Heart Failure With Preserved Ejection Fraction Induced by Chronic Pressure Overload Characterized by Cardiac Fibrosis and Remodeling.

Authors:  Weijiang Tan; Xiang Li; Shuang Zheng; Xiaohui Li; Xiaoshen Zhang; W Glen Pyle; Honghua Chen; Jian Wu; Huan Sun; Yunzeng Zou; Peter H Backx; Feng Hua Yang
Journal:  Front Cardiovasc Med       Date:  2021-06-02

Review 10.  The Role of Metabolism in Heart Failure and Regeneration.

Authors:  Jiyoung Bae; Wyatt G Paltzer; Ahmed I Mahmoud
Journal:  Front Cardiovasc Med       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.